KRONOX · Kronox Lab Sciences Ltd · Chemical Manufacturing
KRONOX · Kronox Lab Sciences Ltd · Chemical Manufacturing
As of 06 Nov close
Price chartDaily closes on the stock page.
Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.
Full signal detail →Fundamentals as of 15 Sep 2026 · the company's own latest record is 53 days old
Revenue (latest Q)
₹28 Cr
Revenue YoY
PAT YoY
+16.2%
Operating margin
Revenue, last 8 quarters
P/E (TTM)
P/B
5.5
P/S (TTM)
6.2
Sector P/E
20.6
Dividend yield
+0.3%
| Company | P/E | P/B | Net margin | ROE | D/E | Div. yield |
|---|---|---|---|---|---|---|
| KRONOX (this stock) | 19.4 | 5.5 | +27.1% | +24.6% | 0.01 | +0.3% |
| Asian Paints | 53 | 11.1 | +12.8% | +22.3% | 0.18 | +1.1% |
| Solar Industries India | 99.6 | 26.6 | +17.6% | +31.4% | 13.68 | +0.1% |
| Pidilite Industries | 61.3 | 19.4 | +17.2% | +24.4% | 0.04 | +0.7% |
Promoter
stable
FII
stable
MF
Not available from data source
Insider trades
| Date | Insider | Type | Qty | Value |
|---|---|---|---|---|
| 29 Sept 2026 | Mr. Jogindersingh Jaswal | SELL | 85,66,400 | ₹88.42 Cr |
| 29 Sept 2026 | Mr. Ketan Ramani | SELL | 85,66,400 | ₹88.42 Cr |
| 29 Sept 2026 | Mr. Pritesh Ramani | SELL | 67,11,200 | ₹69.27 Cr |
Bulk/block deals
| canonicalSymbol | date | buy quantity | buyer count | deal strength | deal types present |
|---|---|---|---|---|---|
| KRONOX | 2026-08-21 | 7225558 | 16 | MEDIUM | BULK |
| KRONOX | 2026-08-20 | 196285 | 1 | WEAK | BULK |
News timeline
No related news.
Concalls & investor presentations
AI-generatedNo concall transcripts or investor presentations recorded yet.
AI Summary of Annual Report
AI-generatedKronox Lab Sciences Limited's annual report for FY2025-26 highlights the company's focus on expanding its manufacturing capabilities and maintaining high-quality standards through various certifications. The report mentions the company's growth in revenue and its efforts in corporate social responsibility, including a significant investment in CSR activities. Additionally, the report outlines the company's compliance with corporate governance practices and its strategic initiatives to enhance its market position.
- Expansion of manufacturing units and acquisition of new facilities to meet growing demand.
- Commitment to quality through multiple certifications such as FSSC 22000, GMP, and ISO standards.
- Increased focus on corporate social responsibility with substantial investments in CSR activities.
- Compliance with corporate governance practices and adherence to statutory requirements.
Key takeaway: Kronox Lab Sciences Limited is emphasizing expansion, quality assurance, and corporate social responsibility as key strategies to strengthen its market position and ensure sustainable growth.
The following annual report excerpts provide qualitative strategic context. Do not treat any specific financial figures in these excerpts as authoritative — they may be incorrectly labeled due to PDF table extraction limitations. For precise financial data, refer to the structured fundamentals data above.
Governance disclosures
AI-generatedNeeds attention
Regulatory Action (1 item)
Items of these kinds are disclosed in the filings. This is a count of disclosed items. It is not a finding about the company and its cause has not been independently established.
Regulatory Action
1 occurrenceEarlier (1-3 years ago)
The company is not compliant with the provisions of the Maternity Benefit Act, 1961.
Routine disclosures
Related-Party Transaction
1 occurrenceEarlier (1-3 years ago)
The company has disclosed transactions with related parties, including entities under significant control of Key Management Personnel (KMP) and relatives of KMP, as per IND AS - 24.
Management & Board Governance
1 occurrenceEarlier (1-3 years ago)
A director of KRONOX LAB SCIENCES LIMITED has been debarred or disqualified by a statutory authority, as noted in the certificate issued by Devesh Pathak & Associates.